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Genetic department, CHU Liège, Belgium. 
Ehlers-Danlos Syndrome (EDS) is a common reason for consulting in clinical genetics. In our genetic consultations, we are confronted with an excessive 
numbers of patients referred for joint hypermobility and/or an electronic microscopy analysis of skin biopsies. In many cases, a dermatologist or a 
physiotherapist has already established a clinical diagnosis of hypermobility type EDS. As recently published by Malfait et al. 1, EDS hypermobility type 
diagnosis is based on clinical findings. Only in this context, a genetics consultation does not seem to be of additional value since no additional analyses are 
indicated to confirm the diagnosis.  
The aim of this study was to characterize patients referred to clinical genetics consultations for EDS suspicion and evaluate the utility of genetics analysis. 
Introduction 
Methods 
We performed a retrospective observational study of the patients from the University Hospital of Liège who had come to a genetic consultation for Ehlers-Danlos syndrome 
or other collagenopathies between March 2016 (date of creation of the consultation dedicated to EDS) and December 2017. We performed a descriptive statistical analysis 
of demographic and clinical characteristics including reason for referral, referee, age, gender, Beighton score, Ehlers-Danlos syndrome associated clinical signs, family history, 
as well as the prescribed complementary tests (heart ultrasound, aortic angio MRI/scan, genetic testing). 
Results 
From March 2016 to December 2017, we have seen 143 patients in the collagenopathies consultation : 123 
women and 20 men, with a mean age of 35.9 (± 14.1) years old.  
111 patients (78.2%) were referred for an Ehlers-Danlos syndrome suspicion based on joint hypermobility. The 
other 32 patients were referred for collagenopathy suspicion (personal or family history of aneurysms), 5 of 
whom presented a marfanoid habitus. 
 
Only two thirds of the patients presented joint hypermobility as assessed by the Beighton score : 60.8% (n=87) 
had a positive Beighton score higher than 5 (mean of 4.95 ± 2.90). This was associated with joint instability in 
most of the cases and generalized arthromyalgia. Only 19% (n=27) of the patients presented skin 
hyperextensibility, 28% (n=40) skin fragility with enlarged scars and only one case presented atrophic 
papyraceous scars. Among the other clinical signs, 11% (n=16) presented arachnodactyly and 14% (n=20) a high 
palate (Table 1). 
 
Regarding family history, 81 patients (57.0%) had at least one relative with joint hypermobility. In 20 patients 
(14.1%) the family history was positive for vascular problems, five patients (3.5%) had a family history positive 
for auto-immune disorders and one patient (0.7%) had a relative with polycystic kidneys. 
 
Clinical characteristics Number of patients 
Dolichostenomelia 5.63% (n=8) 
Repeated strain or luxation 64.08% (n=91) 
Skin hyperelasticity 19.01% (n=27) 
Scars Atrophic scars : 0.7% (n=1) 
Marked scars : 27.97% (n=40) 
Stretch marks : 9.15% (n=13) 
Pectus Excavatum : 9.15% (n=13) 
Carinatum : 4.22% (n=6) 
Varicose veins 11.27% (n=16) 
Arachnodactyly 11.27% (n=16) 
Abnormal palate High : 14.08% (n=20) 
Hypertrophic : 0.7% (n=1) 
Uvula Elongated : 6.34% (n=9) 
Bifid : 1.41% (n=2) 
Table 1 : Clinical characteristics of the patients seen in 
the collagenopathies consultation 
 
Conclusion 
The vast majority (97.8%) of the patients referred for an EDS suspicion presented a hypermobility type or another non-genetic disorder, 
and a genetic consultation did not have any additional value. Since the diagnosis of hypermobile type of EDS is based on clinical findings, it 
is essential to make physiotherapists, rheumatologists and general practitioners aware of this. Specialized training regarding signs or 
symptoms suggestive of rare EDS type or other collagenopathies that can be diagnosed genetically, is essential. Referral criteria should be 
defined in order to select cases needing a clinical genetic evaluation. 
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Genes tested n 
TAAD panel 2 19 
COL5A1 – COL5A2  11 
COL1A1 – COL1A2  1 
COL1A3  1 
FBN1  1 
TGFB3 1 
RPS6KA3 1 
CGH array 4 
Total 41 
Mutations founded n 
Normal result 30 
c.899G (p.Arg300Gln) - TGFB3 2 
c.1234C>T, p.(Arg412*) - MYH11 1 
c.515C>T (p.Thr172Ile) - SLC2A10 1 
c.1531T>C (p.Tyr511His) - FBN1 +  
c.454C>T (p.Arg152Trp) - TGFB3 1 
Duplication 22q11.21 + deletion Xp22.31 1 
In progress 5 
Total 41 
2 The TAAD (thoracic aortic aneurysm and dissection) genes panel : 
ACTA2, BGN, COL3A1, FBLN4, ELN, EMILIN1, FBN1, FBN2, FLNA, 
FOXE3, LMOD1, LOX, MAT2A, MFAP5,MYH11,MYLK,NOTCH1, 
PLOD1, PRKG1,SKI, SCL2A10, SAMD2, SMAD3, SAMD4, TFGFB2, 
TGFB3,TGFBR1,TGBR2. 
 
Table 3 : Genetic tests  
Based on the presence of findings suggestive of an underlying genetic etiology, a genetic analysis was 
performed in 41 patients. Six (4.2%) tested positive (Table 3 and 4). The two patients presenting a TGFB3 
mutation were a mother and daughter with a Loeys-Dietz syndrome. The other three anomalies were 
variants of unknown significance. The duplication/deletion was not related to the symptoms of the 
patient. 
Table 4 : Genetic results 
 
A cardiac ultrasound (Table 2) was performed in 46 patients (28.9%) and other complementary tests 
(aortic angio MRI/scan, RX, …) were performed in 22 patients (15.5%). 
We have diagnosed one patient with classical EDS with so far no molecular confirmation and we 
have diagnosed a familial Loeys-Dietz syndrome (mother and daughter). In three patients (2.2%), the 
genetic results were not conclusive (variants of unknown significance). Except for these rare cases 
where the consultation confirmed the presence of pathology, the majority of the evaluations only 
confirmed the already established diagnosis of benign hypermobility syndrome (57.0%) or excluded 
the presence of a collagenopathy (40.8%). 
 
Cardiac ultrasound results n 
Normal result 37 
Ectasia of the ascending aorta  1 
Mitral insufficiency 1 
Dilatation of the ascending aorta 1 
In progress 8 
Total 46 
Table 2 : Cardiac ultrasound 
